James Kasuboski
Partner and Head of Research at Luma Group
Chicago, Illinois
James Kasuboski, Partner and Head of Research at Luma Group is an active investor based in Chicago, Illinois. This profile covers what James Kasuboski backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPEInvestor
- Stages
- Series A
- Invests in
- Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseConsumer & RetailIoT & Connected Devices
- Location
- Chicago, Illinois
- Typical check
- $1M
- Past investments
- 12
Notable investments
Enara BioTilos Therapeutics
Avilar TherapeuticsReAx BiotechnologiesGlyphic BiotechnologiesBoehringer Ingelheim Venture FundOMX VenturesChicago Biomedical Consortium
Rewind TherapeuticsRA Capital Management, LLCSeeker BiologicsAdvanced Research Projects Agency for Health (ARPA-H)How to reach James Kasuboski
Angels and operators like James Kasuboski reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with James Kasuboski
Frequently Asked Questions
What does James Kasuboski invest in?
James Kasuboski invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Series A. Match your sector and stage, then reach out with a personalized pitch.
What stage does James Kasuboski invest at?
James Kasuboski typically invests at Series A. Lead with traction that fits the stage when you reach out.
What is James Kasuboski's typical check size?
James Kasuboski typically writes checks around $1M. Use it as a signal for whether your raise fits their stage.
How do I contact James Kasuboski?
Unlock James Kasuboski's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.